The first pass metabolism of nifedipine in man.
作者信息
Waller D G, Renwick A G, Gruchy B S, George C F
出版信息
Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x.
Abstract
Oral administration of nifedipine (20 and 30 mg tablets) to six volunteers was associated with a bioavailability of 0.43 and the presence of its nitropyridine analogue in the plasma. This metabolite was present in only trace amounts in samples taken from the same volunteers following i.v. administration of nifedipine. The peak plasma concentrations and area under the plasma concentration-time curve suggest that the nitropyridine analogue is a major, first pass, metabolite of nifedipine.
摘要
相似文献
1
The first pass metabolism of nifedipine in man.
Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x.
2
The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.缓释硝苯地平在志愿者长期给药期间的生物利用度和药代动力学。
Br J Clin Pharmacol. 1986 Apr;21(4):385-8. doi: 10.1111/j.1365-2125.1986.tb05211.x.
3
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.硝苯地平：肾功能对药代动力学/血流动力学关系的影响。
Clin Pharmacol Ther. 1985 May;37(5):563-74. doi: 10.1038/clpt.1985.89.
4
The metabolism and pharmacokinetics of nicardipine hydrochloride in man.盐酸尼卡地平在人体中的代谢及药代动力学
Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):23S-28S. doi: 10.1111/j.1365-2125.1985.tb05141.x.
5
Pharmacokinetics and metabolism of nifedipine.硝苯地平的药代动力学与代谢
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II18-24. doi: 10.1161/01.hyp.5.4_pt_2.ii18.
6
Bioavailability of nifedipine: a comparison between two preparations.
Biopharm Drug Dispos. 1984 Apr-Jun;5(2):109-15. doi: 10.1002/bdd.2510050204.
7
The pharmacokinetics of oral nifedipine--a population study.口服硝苯地平的药代动力学——一项群体研究。
Br J Clin Pharmacol. 1988 Jun;25(6):701-8. doi: 10.1111/j.1365-2125.1988.tb05256.x.
8
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.硝苯地平在正常受试者单次静脉注射和口服后的动力学及生物利用度。
J Clin Pharmacol. 1983 Apr;23(4):161-70. doi: 10.1002/j.1552-4604.1983.tb02720.x.
9
Factors affecting the absolute bioavailability of nifedipine.影响硝苯地平绝对生物利用度的因素。
Br J Clin Pharmacol. 1995 Jul;40(1):51-8. doi: 10.1111/j.1365-2125.1995.tb04534.x.
10
[Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Arzneimittelforschung. 1985;35(12):1840-2.
引用本文的文献
1
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine.应用基于生理学的药代动力学模型理解奥美拉唑给药对口服硝苯地平控释片的药代动力学的影响。
CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):247-256. doi: 10.1002/psp4.13075. Epub 2023 Dec 21.
2
Nanomedicine for Maternal and Fetal Health.纳米医学与母婴健康。
Small. 2024 Oct;20(41):e2303682. doi: 10.1002/smll.202303682. Epub 2023 Oct 10.
3
The Challenge and Importance of Integrating Drug-Nutrient-Genome Interactions in Personalized Cardiovascular Healthcare.在个性化心血管医疗保健中整合药物-营养-基因组相互作用的挑战与重要性。
J Pers Med. 2022 Mar 22;12(4):513. doi: 10.3390/jpm12040513.
4
Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.2型糖尿病对高血压孕妇硝苯地平药代动力学及经胎盘转运的影响。
Br J Clin Pharmacol. 2017 Jul;83(7):1571-1579. doi: 10.1111/bcp.13226. Epub 2017 Jan 29.
5
Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.槲皮素，一种细胞色素P450 3A（CYP3A）的体外抑制剂，并不参与硝苯地平和葡萄柚汁之间的相互作用。
Br J Clin Pharmacol. 1993 Nov;36(5):460-3. doi: 10.1111/j.1365-2125.1993.tb00396.x.
6
A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.氨氯地平和硝苯地平控释片在血压正常受试者中作用持续时间的比较评估。
Br J Clin Pharmacol. 1993 Dec;36(6):561-6. doi: 10.1111/j.1365-2125.1993.tb00415.x.
7
Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects.健康受试者中葡萄柚汁摄入时间与其对非洛地平药代动力学和药效学影响的关系。
Eur J Clin Pharmacol. 1995;49(1-2):61-7. doi: 10.1007/BF00192360.
8
Lack of presystemic metabolism of nifedipine in the rabbit.硝苯地平在兔体内不存在首过代谢。
J Pharmacokinet Biopharm. 1995 Dec;23(6):567-80. doi: 10.1007/BF02353462.
9
Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.硝苯地平动力学的种族差异：尼日利亚人、白种人和南亚人之间的比较。
Br J Clin Pharmacol. 1995 Nov;40(5):489-93.
10
Factors affecting the absolute bioavailability of nifedipine.影响硝苯地平绝对生物利用度的因素。
Br J Clin Pharmacol. 1995 Jul;40(1):51-8. doi: 10.1111/j.1365-2125.1995.tb04534.x.
本文引用的文献
1
High-performance liquid chromatography of nifedipine, its metabolites and photochemical degradation products.
J Chromatogr. 1981 Jun 19;210(3):516-21. doi: 10.1016/s0021-9673(00)80344-1.
2
Occurrence and measurement of nifedipine and its nitropyridine derivatives in human blood plasma.
J Chromatogr. 1982 Sep 10;231(2):451-8. doi: 10.1016/s0378-4347(00)81871-x.
3
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.硝苯地平在正常受试者单次静脉注射和口服后的动力学及生物利用度。
J Clin Pharmacol. 1983 Apr;23(4):161-70. doi: 10.1002/j.1552-4604.1983.tb02720.x.
4
Determination of nifedipine in serum or plasma by reversed-phase liquid chromatography.
Clin Chem. 1983 Jul;29(7):1344-8.
5
Determination of nifedipine in human plasma by capillary gas chromatography with nitrogen detection.采用带氮检测的毛细管气相色谱法测定人血浆中的硝苯地平。
J Chromatogr. 1983 Nov 25;279:675-80. doi: 10.1016/s0021-9673(01)93672-6.
6
[Clinical study on the pharmacokinetics of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].
Arzneimittelforschung. 1972 Feb;22(2):330-4.
Zotero 插件